NRW Holdings Limited Annual General Meeting 26 November 2026 22 October 2026 NRW Holdings Limited 219 St Georges Terrace Perth WA 6000 TAKE NOTICE that the Annual General Meeting of Shareholders will be held at 2.00pm (Perth time) on Thursday, 26…
NRW Holdings Limited
Annual General Meeting
26 November 2026
22 October 2026
NRW Holdings Limited
219 St Georges Terrace
Perth WA 6000
TAKE NOTICE that the Annual General Meeting of Shareholders will be held at 2.00pm (Perth time) on Thursday,
26 November 2026 at 219 St Georges Terrace, Perth, Western Australia for the purposes of transacting the
business referred to in the Notice of Meeting (NOM).
The NOM sets out in detail the full nature of the business to be conducted at the meeting together with details on
how to vote at the meeting. The NOM can be viewed and downloaded at the following link:
https://nrw.com.au/investors/nrwholdings-agm/
A copy of your Proxy Form is enclosed for convenience. Your proxy must be lodged no later than 2:00pm (Perth
time) on Tuesday, 24 November 2026.
If for any reason you are unable to download the notice of meeting a hard copy can be obtained by contacting the
NRW Company Secretary at [email protected].
In accordance with section 110D(1) of the Corporations Act 2001 (Cth) the Company will not be dispatching hard
copies of the NOM to shareholders unless a shareholder has elected to receive a hard copy.
Shareholders are also encouraged to submit any questions in advance of the Meeting to the Company. Questions
must be submitted in writing to the Company at [email protected] at least 48 hours prior to the Meeting.
By Order of the Board
Kim Hyman
Company Secretary
22 October 2026
1
NRW Holdings Limited
ACN 118 300 217
Notice of Annual General Meeting
Notice is given that the 2026 Annual General Meeting of NRW Holdings Limited (Company) will be held on
Thursday, 26 November 2026 at 2.00pm (Perth time). The Meeting will be held at 219 St Georges Terrace, Perth,
Western Australia.
The Explanatory Memorandum, which accompanies and forms part of this Notice of Annual General Meeting
(Notice), describes in detail the matters to be considered. Shareholders should read the Explanatory Memorandum
in full.
By Order of the Board
Kim Hyman
Company Secretary
22 October 2026
2
Items of Business
1.
Financial Statements and Sustainability, Directors’ and Auditor’s reports
To receive and consider the financial statements of the Company, together with the sustainability,
directors’ and auditor’s reports, for the year ended 30 June 2026.
Remuneration Report
To consider and, if thought fit, to pass the following as an ordinary resolution: (Resolution 1)
“That the Company’s remuneration report for the year ended 30 June 2026 be adopted.”
Resolution 1 is advisory only and does not bind the Directors or the Company. The Directors will consider
the outcome of the vote and comments made by shareholders on the 2026 Remuneration Report at the
2026 Annual General Meeting when reviewing the Company’s remuneration policies.
Re-election of Mr. David Joyce
To consider and, if thought fit, to pass the following as an ordinary resolution: (Resolution 2)
“That Mr. David Joyce, who retires in accordance with rule 5.1 of the Constitution and being eligible, is reelected as a Director.”
Approval of Performance Rights Plan
To consider and, if thought fit, pass the following as an ordinary resolution: (Resolution 3)
“That for the purposes of ASX Listing Rule 7.2 (Exception 13(b)) and for all other purposes, approval is
given for the Company to operate the “NRW Holdings Limited Performance Rights Plan” and for the issue
of securities from time to time under the Plan as an exception to ASX Listing Rule 7.1, on the terms and
conditions set out in the Explanatory Memorandum.”
Approval of grant of performance rights for FY27 to Mr Julian Pemberton under the NRW
Holdings Limited Performance Rights Plan
To consider and, if thought fit, to pass the following resolution as an ordinary resolution: (Resolution 4)
“That for the purposes of ASX Listing Rule 10.14, sections 200B and 200E of the Corporations Act 2001
(Cth) and for all other purposes, approval is hereby given for the grant to the Company’s Managing
Director and Chief Executive Officer (CEO), Mr J Pemberton (or his nominee), of 414,345 performance
rights under the terms of the “NRW Holdings Limited Performance Rights Plan” and on the terms and
conditions set out in the Explanatory Memorandum.”
Non-executive Directors’ fees
To consider and, if thought fit, to pass the following as an ordinary resolution: (Resolution 5)
“That approval be given to increase the maximum total remuneration payable to non-executive Directors
under rule 42 of the Constitution and Listing Rule 10.17 from $1,500,000 per annum to $2,500,000 per
annum.”
3
Voting Restrictions
Resolution 1 (Remuneration Report)
Voting prohibition statement
A vote must not be cast on Resolution 1:
a.
b.
by or on behalf of a member of the Company’s or the group’s key management personnel (whose remuneration
is disclosed in the 2026 Remuneration Report) or by a closely related party of such a member, regardless of
the capacity in which the votes are cast; or
by a person who is a member of the Company’s or the group’s key management personnel at the date of the
2026 Annual General Meeting, or by a closely related party of such a member, as a proxy.
However, a person (voter) may cast a vote as a proxy for a person entitled to vote on Resolution 1:
c.
d.
in accordance with a direction that specifies how the proxy is to vote on the resolution; or
if the voter is the Chairperson of the meeting and the appointment of the Chairperson as proxy does not specify
how the proxy is to vote on the resolution and expressly authorises the Chairperson to exercise the proxy even
though the resolution is connected directly or indirectly with the remuneration of a member of the Company’s
or the group’s key management personnel.
Resolution 3 (Approval of Performance Rights Plan)
Voting prohibition statement
A vote must not be cast on Resolution 3 by a person appointed as proxy if:
a.
b.
the proxy is either:
i.
a member of the Company’s or the group’s key management; or
ii.
a closely related party of such a member; and
the appointment does not specify the way the proxy is to vote on the resolution.
However, the above prohibition does not apply if:
c.
d.
the proxy is the Chairperson of the meeting; and
the appointment expressly authorises the Chairperson to exercise the proxy even though the resolution is
connected directly or indirectly with the remuneration of a member of the Company’s or the group’s key
management personnel.
Voting exclusion statement
The Company will disregard any votes cast in favour of Resolution 3 by or on behalf of:
a.
b.
a person who is eligible to participate in the Plan; or
an associate of that person or those persons.
However, this does not apply to a vote cast in favour of a resolution by:
c.
d.
e.
a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with
directions given to the proxy or attorney to vote on the resolution in that way; or
the Chairperson of the meeting as proxy or attorney for a person who is entitled to vote on the resolution, in
accordance with a direction given to the Chairperson to vote on the resolution as the Chairperson decides; or
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
i.
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from
voting, and is not an associate of a person excluded from voting, on the resolution; and
ii.
the holder votes on the resolution in accordance with directions given by the beneficiary to the holder
to vote in that way.
4
Resolution 4 (Approval of grant of performance rights for FY27 to Mr Julian Pemberton under the NRW
Holdings Limited Performance Rights Plan)
Voting prohibition statement
A person appointed as a proxy must not vote, on the basis of that appointment, on Resolution 4 if:
a.
b.
the proxy is either:
i.
a member of the Company’s or the group’s key management personnel; or
ii.
a closely related party of such a member; and
the appointment does not specify the way the proxy is to vote.
However, the above prohibition does not apply if:
c.
d.
the proxy is the Chairperson of the meeting; and
the appointment expressly authorises the Chairperson to exercise the proxy even though the resolution is
connected directly or indirectly with the remuneration of a member of the Company’s or the group’s key
management personnel.
Voting exclusion statement
The Company will disregard any votes cast in favour of Resolution 4 by or on behalf of:
a.
b.
a person referred to in Listing Rule 10.14.1 (being a Director), 10.14.2 or 10.14.3 who is eligible to participate
in the NRW Holdings Limited Performance Rights Plan; or
an associate of that person or persons.
However, this does not apply to a vote cast on Resolution 4 by:
c.
d.
e.
a person as proxy or attorney for a person who is entitled to vote on the resolution, in a person as proxy or
attorney for a person who is entitled to vote on the resolution, in accordance with directions given to the proxy
or attorney to vote on the Resolution in that way;
the Chairperson of the meeting as proxy or attorney for a person who is entitled to vote on the resolution, in
accordance with a direction given to the Chairperson to vote on the resolution as the Chairperson decides; or
a holder acting solely in a nominee, trustee or custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
i.
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from
voting, and is not an associate of a person excluded from voting, on the resolution; and
ii.
the holder votes on the resolution in accordance with directions given by the beneficiary to the holder
to vote in that way.
Resolution 5 (Non-executive Directors’ fees)
Voting exclusion statement:
The Company will disregard any votes cast in favour of Resolution 5 by or on behalf of:
a.
b.
a Director of the Company; or
an associate of that person or those persons.
However, this does not apply to a vote cast in favour of the resolution by:
c.
d.
e.
a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with
directions given to the proxy or attorney to vote on the resolution in that way;
the Chairperson of the meeting as proxy or attorney for a person who is entitled to vote on the resolution, in
accordance with a direction given to the Chairperson to vote on the resolution as the Chairperson decides; or
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
i.
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from
voting, and is not an associate of a person excluded from voting, on the resolution; and
ii.
the holder votes on the resolution in accordance with directions given by the beneficiary to the holder
to vote in that way.
5
Voting prohibition statement:
A person appointed as a proxy must not vote, on the basis of that appointment on Resolution 5 if:
a.
b.
the proxy is either:
i.
a member of the Company’s or the group’s key management personnel; or
ii.
a closely related party of such a member; and
the appointment does not specify the way the proxy is to vote.
However, the above prohibition does not apply if:
c.
d.
the proxy is the Chairperson of the meeting; and
the appointment expressly authorises the Chairperson to exercise the proxy even though the resolution is
connected directly or indirectly with the remuneration of a member of the Company’s or the group’s key
management personnel.
6
Voting
Voting entitlements
For the purposes of regulation 7.11.37 of the Corporations Regulations 2001 (Cth), the Company has determined
that the shareholding of each person for the purpose of determining entitlements to attend and vote at the 2026
Annual General Meeting will be based on registered holdings set out in the Company’s share register as at 4:00pm
(Perth time) on Tuesday, 24 November 2026. Accordingly, transactions registered after that time will be
disregarded in determining entitlements to attend and vote at the 2026 Annual General Meeting.
How to vote
Voting in person
A shareholder of the Company who is an individual may attend and vote in person at the 2026 Annual General
Meeting. If you wish to attend the 2026 Annual General Meeting, please bring the attached proxy form to the
meeting to assist in registering your attendance and number of votes. Please arrive 15 minutes prior to the start of
the meeting to facilitate this registration process.
A shareholder that is a corporation may appoint an individual to act as its representative to vote at the 2026 Annual
General Meeting in accordance with section 250D of the Corporations Act 2001 (Cth) (Corporations Act). The
appropriate “Appointment of Corporate Representation” should be produced prior to admission. A form of the
appointment may be obtained from the Company’s share registry or at https://www.mpms.mufg.com/en/forindividuals/au/shareholders/forms/.
This year, we are pleased to offer shareholders who are attending the meeting in person a way to cast their vote
using their mobile device. Shareholders can download the Vote+ App from the Apple App Store or Google Play at
any time prior to the Meeting and use the Vote+ App during the Meeting to cast a vote.
Paper voting cards will be available at the meeting for shareholders who attend in person.
Voting by proxy
A shareholder of the Company has the right to appoint a proxy, who need not be a shareholder, to attend the 2026
Annual General Meeting and vote on their behalf. A proxy form is incorporated with this Notice. If an additional
proxy form is required, the Company’s share registry will supply it on request.
You should complete the proxy form if you do not wish to attend the 2026 Annual General Meeting and wish to
appoint a proxy to attend and vote on your behalf. If you intend to attend the 2026 Annual General Meeting, you
do not need to complete the proxy form. However, please bring the proxy form with you to the meeting to assist
with your registration. To be valid, the proxy form (and any power of attorney under which it is signed) must be
signed in accordance with the instructions set out on the form and must be received by 2.00 pm (Perth time) on
Tuesday, 24 November 2026. Your proxy form can be returned as follows:
By mail to:
MUFG Corporate Markets (AU)
Locked Bag A14
Sydney South NSW 1235
Hand delivered to:
MUFG Corporate Markets (AU)
Parramatta Square Level 22 Tower 6
10 Darcy Street
Parramatta NSW 2150
By facsimile to:
MUFG Corporate Markets (AU) on +61 2 9287 0309
Lodged online:
At https://au.investorcentre.mpms.mufg.com. Select Investor Login and in the ‘Single Holding’ section enter
‘NRW Holdings Limited’ or ‘NWH’ as the Issuer Name and enter your holding details as shown on your proxy
form (Securityholder Reference Number (SRN) or Holder Identification Number (HIN) and postcode as shown
on the front of your Proxy Form), complete the security process and follow the prompts to lodge your proxy. You
will be taken to have signed your proxy form if you lodge it in accordance with the instructions given on the
website.
7
You may still attend the 2026 Annual General Meeting even if you have appointed a proxy. However, your proxy’s
authority to speak and vote for you at the meeting is suspended while you are present at the meeting.
If you are entitled to cast two or more votes, you may appoint up to two persons to act as your proxy and vote at
the 2026 Annual General Meeting on your behalf. If you wish to do this, you must use a separate proxy form in
respect of each proxy and indicate the percentage of your voting rights or the number of shares that each proxy is
appointed in respect of on the proxy forms. If the appointment does not specify the proportion or the number of the
shareholder’s votes, each proxy may exercise half of the votes. You should photocopy the attached proxy form or
request the Company’s share registry to send an additional proxy form.
If you wish to direct your proxy how to vote on any or all of the resolutions, place a mark “X” in the “For”, “Against”
or “Abstain” box. If you do not direct your proxy how to vote, your proxy may vote as he, she or it sees fit. If you
mark the abstain box, you are directing your proxy not to vote on your behalf in respect of that resolution and your
votes will not be included on a show of hands or on a poll.
If you choose to appoint a proxy, you are encouraged to direct your proxy how to vote by placing a mark
“X” in the “For”, “Against” or “Abstain” box on the proxy form for each item of business.
If you appoint the Chairperson as your proxy, but do not give directions on how to vote on a particular resolution,
the Chairperson will vote in accordance with his stated voting intentions.
In respect of Resolutions 1, 2, 3, 4 and 5, if you appoint the Chairperson as your proxy (or the Chairperson
becomes your proxy by default), but you do not give directions on how to vote in relation to the Resolution,
you will be authorising the Chairperson to vote in accordance with his stated voting intention which is to
vote in favour of the Resolution, subject to any voting restrictions that may apply.
Attorneys
If an attorney for a shareholder is to vote at the 2026 Annual General Meeting, the instrument conferring the power
of attorney or a certified copy must be provided to the Company in the same manner as proxies not later than 48
hours before the time for holding the 2026 Annual General Meeting.
8
Questions from Shareholders
About the management of the Company and on the Remuneration Report
The Chairperson will allow a reasonable opportunity for shareholders to ask questions or make comments on the
management of the Company and on the 2026 Remuneration Report. If you would like to submit a question on
these matters prior to the 2026 Annual General Meeting for it to be addressed, you may email your question to the
Company Secretary at [email protected].
About the auditors’ report and conduct of the audit
Deloitte, as the auditor responsible for preparing the auditor’s report for the period ended 30 June 2026, will attend
the 2026 Annual General Meeting. The Chairperson will allow a reasonable opportunity for the shareholders to ask
the auditor questions about the conduct of the audit, the preparation and content of the auditor’s report, the
accounting policies adopted by the Company in relation to the preparation of the financial statements and the
independence of the auditor in relation to the conduct of the audit.
Shareholders may also submit written questions to Deloitte to be answered at the 2026 Annual General Meeting
in relation to the content of the auditor’s report or the conduct of the audit of the Company’s financial statements
for the period ended 30 June 2026. Written questions of the auditor must be received no later than 5 business days
before the 2026 Annual General Meeting. Written questions may be submitted to the Company Secretary,
[email protected]. A list of qualifying questions will be made available to shareholders.
9
Explanatory Memorandum
This Explanatory Memorandum contains background material to assist shareholders in relation to the items of
business to be considered at the 2026 Annual General Meeting and in deciding how to vote on the resolutions set
out in this Notice.
Item 1. Financial and other Reports
The Corporations Act requires the Directors to lay before the 2026 Annual General Meeting the financial
statements, the Directors’ report and the auditor’s report for the year ended 30 June 2026. These reports are
contained in the Company’s 2026 Annual Report, which has been released to the ASX and is available from the
Company’s website www.nrw.com.au.
While no resolution is required in relation to this item, shareholders will be provided with a reasonable opportunity
to ask questions or make statements on the financial statements and reports.
The Company’s auditor, Deloitte, will be present at the AGM and shareholders will have an opportunity to ask the
auditors questions in relation to the conduct of the audit, the auditors report, the Company’s accounting policies
and the independence of the auditor.
Item 2. Remuneration Report (Resolution 1)
Section 250R(2) of the Corporations Act requires that a resolution that the 2026 Remuneration Report be adopted
be put to vote at the 2026 Annual General Meeting. The 2026 Remuneration Report is set out on pages 52 - 79 of
the 2026 Annual Financial Statements.
The vote on this resolution is advisory only, does not bind the Directors or the Company and does not affect the
employment arrangements in place for employees of the Company and its subsidiaries. The Directors will consider
the outcome of the vote and comments made by shareholders on the 2026 Remuneration Report when reviewing
the Company’s future remuneration policies.
The Company’s remuneration report:
•
•
•
•
defines the Company’s remuneration strategy, governance framework and guiding principles;
sets out the components of the remuneration framework, including value, performance conditions and key
terms and conditions;
describes how business performance for the financial year has driven remuneration outcomes; and
sets out the remuneration of non-executive directors, the executive director and key management
personnel
At the 2025 Annual General Meeting, the Company received its eighth consecutive vote against the 2025
Remuneration Report. The Board acknowledges that this outcome reflected continued shareholder concerns
regarding aspects of the Company’s remuneration framework and recognises the importance of demonstrating
meaningful and sustained responsiveness to shareholder feedback.
Following the 2025 AGM, the Nomination and Remuneration Committee (N&RC) and Company Executives
continued engagement with shareholders and proxy advisors to understand the key drivers of the vote. The
feedback received, together with independent remuneration advice, has informed the continued review and
development of the executive remuneration framework.
Changes implemented for FY26 included:
•
•
•
•
•
strengthening the Long-Term Incentive Plan (LTI) design through the introduction of a positive TSR
gateway, the introduction of two TSR comparator groups, expansion of the relative TSR Comparator group
from six to ten companies, an increased weighting to TSR within the LTI allocation, and assessment of
EPS performance over the full three-year performance period;
improving the timeliness and transparency of LTI vesting disclosures;
strengthening the STI framework, including the safety component and application of a fatality gateway;
removing positive Board discretion and adjustments to the LTI performance assessment; and
undertaking independent benchmarking of Executive Key Management Personnel (Executive KMP)
remuneration, with a particular focus on remuneration mix, market positioning and internal relativities.
10
The Board retains the right to moderate any award earned downwards in circumstances where it considers
appropriate.
Further changes have been made for FY27 following continued shareholder and proxy adviser engagement and
independent remuneration benchmarking, including:
•
•
•
•
increasing the EPS CAGR performance hurdles under the LTI to 8% at threshold and 11% at maximum,
the rationale for which is considered further below;
introducing a 25% deferral of the Short-Term Incentive Plan (STI) award earned by Executive KMP for 12
months;
strengthening the STI cash management measure, including increasing the minimum cash conversion
hurdle to 85%; and
incorporating psychosocial risk management into the STI framework.
The Board considers that the changes implemented across FY26 and FY27 demonstrate the continued evolution
of the remuneration framework and demonstrate its commitment to responding to shareholder feedback, while
ensuring the framework continues to support the attraction and retention of executives and the delivery of
sustainable long term shareholder value.
The Board does not make any recommendations to shareholders in relation to Resolution 1 as it is intended to
provide guidance to the Board.
Item 3. Re-election of Mr. David Joyce (Resolution 2)
Rule 5.1 of the Constitution requires that, at the Annual General Meeting, one-third of the Directors for the time
being or, if their number is not 3 or a multiple of 3, the number nearest to but not exceeding 1/3 retire from office.
Pursuant to rule 5.4 of the Constitution, a retiring Director is eligible for re-election without the necessity of giving
any previous notice of his intention to submit himself for re-election.
Mr Joyce was appointed as a Non-Executive Director on 19 March 2024. Mr Joyce is a former mining executive
with over 30 years experience delivering major projects across Australia and internationally. His career includes
engineering roles with Kinhill Engineers and WMC Resources, followed by senior leadership positions at Rio Tinto,
where he concluded his executive tenure in 2021. He has overseen the development of infrastructure, services,
processing facilities, and initial mining operations both underground and open-pit, for greenfield and brownfield
projects worldwide. Highly skilled in industry operations and health, safety and wellbeing, Mr Joyce holds deep
technical and operational insight into complex project environments. In addition to this experience, Mr Joyce is
skilled in sustainability and climate-related matters including but not limited to environmental impacts and emerging
regulations. This experience has been attained practically through his career and includes more recent attendance
at both formal and informal AICD webinars and forums on relevant matters. He holds a Bachelor of Engineering
(First Class Honours) from the University of Adelaide and is a member of the Australian Institute of Company
Directors.
Mr Joyce has not held any other directorships of listed companies in the three years immediately before the end of
the financial year.
With the exception of Mr Joyce, the Board unanimously recommends that Shareholders vote in favour of Resolution
2 given Mr Joyce’s global mining and major-project experience and his expertise in complex project delivery,
operational leadership and sustainability. Mr. Joyce does not make any recommendation to Shareholders in relation
to this resolution as he is subject to the re-election.
Item 4. Approval of Performance Rights Plan (Resolution 3)
ASX Listing Rule 7.1 provides that a company must not, subject to specified exceptions, issue or agree to issue
more equity securities during any 12-month period than that amount which represents 15% of the number of fully
paid ordinary securities on issue at the commencement of that 12-month period. ASX Listing Rule 7.2 (Exception
13(b)) sets out an exception to ASX Listing Rule 7.1 which provides that issues under an employee share scheme
are exempt for a period of three years from the date on which shareholders approve the issue of securities under
the scheme as an exception to ASX Listing Rule 7.1.
At the 2023 Annual General Meeting, shareholders approved the adoption of the NRW Holdings Limited
Performance Rights Plan (the Plan), under which eligible participants could be granted performance rights to
acquire shares in the Company, subject to satisfaction of any conditions imposed in relation to the grant. The
Company is now seeking shareholder approval for the Plan in order to renew the approval obtained pursuant to
ASX Listing Rule 7.2 (Exception 13(b)).
11
If Resolution 3 is passed, the Company will be able to issue securities under the Plan over a period of three years
without impacting on the Company’s ability to issue up to 15% of its total ordinary securities without shareholder
approval in any 12-month period. In the case of a Director, no securities will be issued pursuant to the Plan without
separate prior shareholder approval under ASX Listing Rule 10.14.
If Resolution 3 is not passed, the issue of performance rights under the Plan will contribute towards the Company’s
15% maximum issue of total ordinary securities without shareholder approval. This means that additional
shareholder approval may be required should the Company exceed 15% during any 12-month period.
A total of 9,659,655 performance rights have been allocated under the Plan since the last approval at the 2023
Annual General Meeting. The maximum number of performance rights to be issued over the following three years
under Resolution 3 is 11,500,000, which is proposed to be issued to members of our Executive Leadership team
and senior management within our businesses.
In accordance with Exception 13(b) of Listing Rule 7.2, the terms and conditions of the Plan are at Appendix 1.
With the exception of Mr J Pemberton, the Board unanimously recommends that shareholders vote in favour of
Item 5. Mr J Pemberton does not make any recommendation in relation to this resolution, as he has an interest in
the outcome of the resolution by virtue of him being entitled to participate in the Plan.
Item 5. Approval of grant of Performance Rights for FY27 to Mr Julian Pemberton under the NRW Holdings
Limited Performance Rights Plan (Resolution 4)
The Company is proposing to issue 414,345 performance rights to Mr J Pemberton under the Plan. The Company
has decided to grant the performance rights to Mr J Pemberton because they create share price alignment between
Mr J Pemberton and shareholders but do not provide the full benefits of share ownership (such as dividends and
voting rights) unless the performance rights vest.
ASX Listing Rule 10.14 requires that shareholder approval must be obtained for the acquisition of securities by,
amongst others, a director of a company under an employee incentive scheme. ASX Listing Rule 10.14.1 applies
to the issue of performance rights because Mr J Pemberton is the Managing Director and CEO of the Company.
Resolution 4 thus seeks the required shareholder approval to issue the performance rights to Mr J Pemberton
under and for the purposes of ASX Listing Rule 10.14.
If Resolution 4 is passed, the Company will issue 414,345 performance rights to Mr J Pemberton as soon as
practicable after the date of the 2026 Annual General Meeting and in any event within 12 months of the date of the
meeting. Upon vesting, subject to the relevant performance targets described below, each performance right will
entitle Mr J Pemberton to one fully paid ordinary share in the Company.
If Resolution 4 is not passed, the proposed grant of the performance rights will not proceed and the Board will need
to, acting reasonably and consistent with the Company’s remuneration policies, determine the amount and form of
the compensation payable to Mr J Pemberton for the loss of the benefit of the performance rights, which may
include providing an equivalent long term cash incentive subject to the same risk of forfeiture, performance targets
and performance periods as described below in respect of the grant of the performance rights.
Details of remuneration structure of CEO
The structure of the CEO’s remuneration is a combination of a fixed annual salary and a variable at risk annual
award comprising a short term incentive and a long term incentive, details of which are set out in the 2026
Remuneration Report on pages 52 – 79 of the 2026 Annual Financial Statements.
The remuneration structure has been designed to prioritise strong performance outcomes by ensuring a significant
portion of CEO remuneration is “at-risk” and directly aligned with shareholder results, while also supporting the
retention of the CEO. The Board remains comfortable with the maximum total fixed versus “at-risk” split of the
CEO’s remuneration, with majority of “at-risk” reward comfortably weighted towards long-term equity awards.
There have been no changes to Mr J Pemberton’s remuneration structure for FY27. His Total Fixed Remuneration
(TFR) remains $1,750,000, with a maximum STI opportunity of 80% of TFR and a maximum LTI opportunity of
170% of TFR.
Resolution 4 seeks shareholder approval for the issue of performance rights to Mr J Pemberton which, if granted,
will form part of his remuneration.
12
Key terms of the performance rights issue
It is proposed that, if Resolution 4 is approved, Mr J Pemberton will be granted 414,345 performance rights for the
FY27 financial year (FY27 Award). Key terms associated with the grant are as follows:
•
•
•
•
•
Three-year performance period (1 July 2026 to 30 June 2029).
Vesting date of 30 September 2029.
Vesting of performance rights will be subject to meeting certain performance targets set out below.
Each Performance Right will, on vesting, entitle the holder to one fully paid ordinary share in the Company.
As the performance rights are part of Mr J Pemberton’s remuneration, there is no price payable on the
issue of performance rights or on allocation of shares if Performance Rights vest.
The number of performance rights proposed to be granted pursuant to Resolution 4 was determined using a 30day volume-weighted average price (VWAP) of shares in the Company to 30 June 2026 (which was $7.18 per
share). Accordingly, without applying any discount for the probability of vesting hurdles being satisfied (and if so,
to what extent), this implies a value of $2,975,000 for those performance rights.
Performance targets and vesting
The performance rights proposed to be granted pursuant to Resolution 4 are designed to align the CEO’s
remuneration with the delivery of sustainable earnings growth and long term shareholder value.
The FY27 performance rights will be assessed over a three-year performance period against Relative Total
Shareholder Return (Relative TSR) and underlying Earnings Per Share (EPS) performance hurdles as follows:
Performance hurdle
Weighting
Target 1
Target 2
Relative TSR – Comparator Peer
Group
33.34%
50th percentile
At or above 75th percentile
Relative TSR – Sector Anchor Index
33.34%
50th percentile
At or above 75th percentile
Underlying EPS
33.32%
8% CAGR / 50.1 cps
11% CAGR / 54.4 cps
Total
100%
If performance is above the Target 1 but below the Target 2, the performance rights will vest pro rata to actual
achievement. Measurement of performance against the targets will be based on achieving the targets within the
performance period. The quantum of performance rights that will vest as each performance hurdle is met is shown
in the table below.
Performance Hurdle
Relative TSR –
Comparator Peer Group
Relative TSR – Sector
Anchor Index
Underlying EPS
Total
Vesting Level
% of Performance Rights
No. Performance Rights
Target 1
16.67%
69,071
Target 2
16.67%
69,071
Target 1
16.67%
69,071
Target 2
16.67%
69,071
Target 1
16.66%
69,030
Target 2
16.66%
69,031
100%
414,345
Relative TSR
Relative TSR represents 66.68% of the FY27 LTI and is assessed equally against a Comparator Peer Group and
an objective Sector Anchor Index. If an entity in the group ceases to be listed during the Performance Period (for
example, through a takeover), its TSR will be excluded from the Comparator Peer Group TSR calculation.
13
Measure
Weighting
Comparator
Peer Group
33.34%
Sector Anchor
Index
33.34%
Assessment
NRW’s TSR relative to ten selected like-for-like peers: Macmahon,
Monadelphous, Emeco, SRG Global, Southern Cross Electrical, Perenti,
Civmec, Downer, GR Engineering and Symal.
NRW’s TSR assessed against constituents of the S&P/ASX 200
Industrials Index.
No performance rights subject to a Relative TSR hurdle will vest unless NRW’s absolute TSR over the performance
period is positive. For each Relative TSR component, 50% of the relevant component will vest at the 50th
percentile, with pro rata vesting to 100% at the 75th percentile.
Last year, based on a detailed and independent benchmarking report received from the N&RC, the Comparator
Peer Group was expanded from six to ten companies and the sector anchor introduced to provide a broader and
more robust assessment of NRW’s relative shareholder performance. Following positive feedback and approval of
the FY26 performance rights plan at the 2026 Extraordinary General Meeting, this structure has been retained in
FY27.
EPS Performance Hurdle
Underlying EPS represents 33.32% of the FY27 LTI and will be assessed at the end of the three-year performance
period. Following review, the Board increased EPS CAGR hurdles from 5% and 10% to 8% and 11%, respectively.
Target 1
Target 2
3-year EPS CAGR
8.0%
11.0%
EPS target
50.1 cps
54.4 cps
If performance is above Target 1 but below Target 2, the Performance Rights subject to the EPS hurdle will vest
on a pro-rata basis. In setting Target 1 at 8% and Target 2 at 11%, the Board considered the following:
Consideration
Board assessment
FY27 expected growth
FY27 guidance at its midpoint implies EPS growth of approximately 12.6%.
Impact of Fredon
8% - Target 1
11% - Target 2
Higher stretch Target 2
Acquisition discipline
FY27 growth includes the benefit of the Fredon acquisition. Underlying likefor-like growth is estimated at approximately 8.7%.
Considered to provide an appropriate balance between shareholder
expectations and a challenging hurdle for participants.
Requires sustained double-digit growth beyond FY27 and was considered
to provide a meaningful stretch over the performance period.
The Board considered 12.5% CAGR but determined this would require
sustained growth of approximately 12.4% in both FY28 and FY29 and would
likely necessitate additional acquisitions to be achieved..
The Board does not consider the LTI should incentivise acquisitions merely
to achieve the EPS hurdle. Acquisitions should continue to be pursued only
where strategically aligned and value accretive.
The effect of different CAGR hurdles on the growth required in the remaining years of the performance period was
also considered:
Potential EPS CAGR hurdle
FY27 growth
FY28 growth required
FY29 growth required
7.5%
12.6%
5.0%
5.0%
8.0%
12.6%
5.8%
5.8%
10.0%
12.6%
8.8%
8.8%
11.0%
12.6%
10.2%
10.2%
12.5%
12.6%
12.4%
12.4%
14
The Board also considered peer LTI arrangements. Peer EPS growth hurdles of companies with comparable size
and earnings base ranged between 5% and 10%. The Board therefore determined that setting the Company’s
Target 1 at 8% and Target 2 at 11% exceeded those peer EPS growth hurdles. The Board noted that some peer
companies with higher EPS growth hurdles are materially smaller than NRW and therefore may be capable of
generating higher percentage growth from a lower earnings base.
Other LTI Plan Features
The FY27 LTI also includes the following features:
• EPS will be tested at the end of the three-year performance period;
• EPS will be based on the weighted average number of shares on issue;
• no positive Board discretion will apply to the award;
• a positive absolute TSR gateway applies before any Relative TSR vesting can occur; and
• vesting outcomes will be disclosed at the end of the performance period.
Other key provisions of the Plan for Plan participants
The Plan forms part of the remuneration framework of the Company and is in place to attract and retain key
personnel. Eligibility for participation in the Plan will be subject to approval by the CEO & Managing Director,
Nomination & Remuneration Committee and Board.
If a Plan participant’s (including Executive KMP) employment with the Company ceases for reasons other than
death or permanent disability, any unvested performance rights will lapse and expire unless the Board of the
Company considers it appropriate in the circumstances to consider the vesting of any unvested performance rights.
Where a Plan participant has died or becomes permanently disabled the Board may determine that the
performance rights will not lapse and will be tested against the vesting hurdles on the applicable vesting dates.
Upon a change of control occurring in respect of the Company, the following rules will apply to determine how
performance rights should vest or lapse.
•
•
•
Performance rights that have met the vesting hurdle will vest on a date to be determined before the change
of control date.
Performance rights which have met the vesting hurdle as a consequence of the change of control (for
example a share price increment) will vest on a date to be determined before the change of control date.
In respect of performance rights which have not yet met the vesting hurdle, the N&RC may (in its absolute
discretion) determine that all or a portion of these performance rights will vest, notwithstanding that time
restrictions or performance conditions applicable to the performance rights have not been satisfied.
Vesting in this regard would be subject to shareholder approval.
A Plan participant can be considered to be a “good leaver” subject to agreement with the N&RC. Good leaver
conditions are generally very specific to the individual and the individual’s personal circumstances but will normally
require appropriate notice periods to allow the orderly transfer of responsibilities from the incumbent to his or her
replacement. Any performance rights awarded to a good leaver will be pro rated based on the number of months
of completed employment in the performance period divided by the relevant performance period. Awards will then
be tested at the relevant vesting date (or the date relevant to the performance hurdle) and the pro rated number of
performance rights will vest on the vesting date.
Mr J Pemberton is the only Director entitled to participate in the Plan.
Shares acquired on vesting of performance rights may be delivered to participants through the issue of shares or
on-market acquisitions, at the discretion of the Board. The performance rights will not carry any voting rights and
do not give the holder a right to participate in any entitlement issues (such as pro rata rights issues or a share
purchase plan). The performance rights will not be eligible for any dividends. Any new shares issued on the vesting
of performance rights will be quoted on the ASX. Performance rights will not be quoted on the ASX. Variations to
the terms of the performance rights following their issue is subject to the Plan and the ASX Listing Rules. No
security interests (such as charges or mortgages) can be held against performance rights.
Information for the purposes of ASX Listing Rule 10.15 regarding Resolution 4
The following information is disclosed in relation to Resolution 4 for the purpose of ASX Listing Rule 10.15:
•
•
The performance rights will be granted to Mr J Pemberton (or his nominee).
Mr J Pemberton is covered by Listing Rule 10.14.1 because he is the Company’s CEO and Managing
Director.
15
•
•
•
•
•
•
•
•
•
•
•
The maximum number of performance rights that will be granted to Mr J Pemberton (or his nominee) if
shareholders approve Resolution 5 is 414,345.
Each performance right entitles the holder, on vesting, to receive one fully paid ordinary share in the
Company (subject to any permitted adjustment under the rules of the Plan).
A summary of the material terms of the performance rights and the value that the Company attributes to
the performance rights are set out on pages 12 - 14 above.
Details of Mr J Pemberton’s current total remuneration package are included above. Further details of Mr
J Pemberton’s remuneration are set out in the 2026 Remuneration Report on pages 52 - 79 of the 2026
Annual Financial Statements.
Mr J Pemberton has been granted a total of 2,312,909 performance rights under the Plan at nil cost as
each time they were granted to Mr J Pemberton as part of his remuneration. If Resolution 4 is approved,
that number will be increased by 414,345 performance rights. To date 2,233,906 performance rights have
vested to Mr J Pemberton under the Plan.
The performance rights will be issued as soon as practicable after the date of the 2026 Annual General
Meeting and in any event within 12 months of the date of the meeting.
The performance rights are being granted to Mr J Pemberton as part of his remuneration and therefore
no amount is payable by Mr J Pemberton for the grant of the performance rights. No amount is payable
for any Shares allocated on the vesting of any performance rights.
A copy of the terms and conditions of the Plan can be found on the NRW website (www.nrw.com.au).
There is no loan proposed in relation to the grant of performance rights to Mr J Pemberton.
Details of any securities issued under the Plan will be published in the Company’s annual report relating
to the period in which they were issued, along with a statement that approval for the issue was obtained
under ASX Listing Rule 10.14. Any additional persons covered by ASX Listing Rule 10.14 who become
entitled to participate in an issue of securities under the Plan after Resolution 3 is approved and who are
not named in the Notice will not participate until approval is obtained under ASX Listing Rule 10.14.
A voting exclusion for Resolution 4 is set out in this Notice.
With the exception of Mr J Pemberton, the Board unanimously recommends that Shareholders vote in favour of
Resolution 4. Mr J Pemberton does not make any recommendation to Shareholders in relation to Resolution 4 as
he has an interest in the outcome of the resolution.
Item 6. Non-executive Directors’ fees (Resolution 5)
Under rule 42 of the Constitution and Listing Rule 10.17, shareholder approval is being sought to increase the
maximum aggregate fees payable to non-executive Directors from $1,500,000 per annum to $2,500,000 per
annum, to be allocated between them in such a manner as the Board determines.
The maximum aggregate fees available to be paid to non-executive Directors was last increased in 2021, and the
Company confirms this limit has not been exceeded. Details of Non-executive Director fees are outlined in the 2026
Remuneration Report contained on page 78 of the 2026 Annual Financial Statements. The reasons for requesting
that shareholders approve the increase to the maximum aggregate fees payable to the Company’s non-executive
Directors are as follows:
•
•
•
•
Having regard to the Fredon acquisition and acknowledging the new skills and experience this segment
requires, the Board considers that the proposed increase is necessary to provide the Board with the
capacity to offer suitable remuneration to any proposed new non-executive Directors in the future, if they
determine that this is in the best interests of, and commensurate with the size the Company.
Given the continued evolution and growth of the Group, most recently through the establishment of the
Electrical, Mechanical (HVAC), Infrastructure, Technology and maintenance services (EMIT) segment,
the Board believes it is appropriate to have capacity to consider future fee increases commensurate with
the increased complexity of the group and in line with peer group fee structures.
The Board considers that the proposed increase will assist with succession planning for key Board roles
to support orderly renewal, continuity and appropriate transition and handover arrangements.
The Company does not intend to allocate the full amount of the maximum aggregate remuneration
immediately and such amount is simply the maximum that the Company will be allowed to pay its nonexecutive Directors in aggregate without further shareholder approval.
The proposal is consistent with the objectives of the Company’s Charter of the Nomination and Remuneration
Committee of having remuneration policies designed to attract directors with the expertise to enhance performance
and growth of the Company and ensuring that the level and composition of remuneration packages is fair,
reasonable and adequate. If Resolution 5 is passed, the effect will be that the Company will have the flexibility to
pay its non-executive directors fees of up to an aggregate amount of $2,500,000 per annum. If Resolution 5 is not
passed the maximum aggregate fees payable to non-executive Directors will remain at $1,500,000, and the Board
will lose the flexibility it is seeking to provide sufficient scope for possible Board expansion, succession planning
and ongoing flexibility potentially impacting the Company’s ability to retain existing and/or attract new directors.
16
The Company confirms that no securities have been issued to non-executive Directors in the preceding three years
under Listing Rules 10.11 or 10.14.
The Board does not make any recommendations to Shareholders in relation to Resolution 5 as a majority of the
Board (being non-executive Directors) have an interest in the outcome of the resolution.
17
Appendix 1 – Terms and Conditions of the NRW Holdings Limited Performance
Rights Plan
1.
INTRODUCTION
1.1 Name of the Plan
This Plan is called the “NRW Holdings Limited Performance Rights Plan”.
1.2 Object of the Plan
The object of the Plan is to:
(a) provide Participants with an incentive plan which recognises their ongoing contribution to the achievement
by NRW of long term strategic goals;
(b) establish an employee share scheme as stated in clause 1.3 which is eligible for relief from the disclosure
requirements in Part 7.9 of the Corporations Act under an ASIC instrument (“ASIC Instrument”);
(c) align the interests of Participants with Security Holders through the sharing of a personal interest in the
future growth and development of NRW as represented in the price of NRW Securities; and
(d) provide a means of attracting and retaining skilled and experienced employees.
1.3 Tax
This Plan is a Plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to
the conditions in that Act).
2.
DEFINITIONS AND INTERPRETATIONS
2.1 Definitions
In these Terms & Conditions unless the context otherwise requires:
“Administrator” means any person engaged by the Board to carry out the day-to-day administration of the Plan
as contemplated by clause 8.2(f).
“Applicable Law” means any one or more or all, as the context requires, of:
(a)
(b)
(c)
(d)
(e)
(f)
the Corporations Act;
the Listing Rules;
the Constitution;
the Tax Act;
any practice note, policy statement, class order, declaration, guideline, policy, procedure, ruling or other
guidance note made to clarify or expand (a), (b), (c) or (d) above; and
any other legal requirement that applies or may apply to the Plan.
“ASIC” means the Australian Securities and Investments Commission.
“ASX Settlement Operating Rules” means the operating rules of ASX Settlement Pty Limited
ABN 49 008 504 532.
“ASX” means ASX Limited ABN 98 008 624 691 or the market conducted by it. NRW Holdings Limited Performance
Rights Plan Terms & Conditions.
“Board” means the board of directors of NRW or a person to whom any authority has been delegated under clause
8.2(d).
“Business Day” means a day as defined in Chapter 19 of the ASX Listing Rules.
“Constitution” means the Constitution of NRW.
“Control” of an entity means having the right:
(a) to vote 50% (or more) of the votes that can be cast on the election or removal of the entity’s directors;
(b) to appoint or remove directors who possess 50% (or more) of the votes exercisable by all directors of the
entity; or
18
(c) to 50% (or more) of the profits or distributions of the entity or of its net liquidation proceeds.
“Control Event” means any of the following:
(a) an offer is made by a person for all of the ordinary shares of NRW (or any part as is not at the time owned
by the offeror or any associate of the offeror) and after announcement of the offer the offeror (being a
person who did not Control NRW prior to the offer) acquires Control of NRW and the offer becomes
unconditional; or
(b) any other event which the Board reasonably considers has the characteristics of and should be regarded
as a Control Event in respect of NRW.
“Corporations Act” means the Corporations Act 2001 (Cth).
“Date of Registration” means with respect to a Right, the date that the Right is granted to the Participant, as
determined by NRW and in respect to Securities means the date of allotment or recording of the Participant in the
register of members under the ASX Settlement Operating Rules.
“Eligible Employee” means any employee or executive director of the Group whom the Board decides in its
absolute discretion is eligible to be invited to receive a grant of Rights in the Plan from time-to-time and who is not
prohibited from participating in the Plan by virtue of these Terms & Conditions.
“Grant Date” means the date determined by the Board and specified in the Invitation being either:
(a) the date on which the Rights will be allotted; and/or
(b) the basis on which the date on which the Rights will be acquired is to be determined.
“Group” means NRW and its Related Bodies Corporate.
“Invitation” means an invitation under clause 3.1.
“Legal Personal Representative” means:
(a) the executor of the will or an administrator of the estate of a deceased person;
(b) the trustee of the estate of a person under a legal disability; or
(c) any beneficiary of the estate of the deceased person as nominated by the executor, administrator or
trustee.
“Listing Rules” means the official listing rules of the ASX as they apply to NRW.
“Market Value” has its ordinary meaning as determined in the unfettered discretion of the Board.
“NRW” means NRW Holdings Limited ACN 118 300 217.
“Offer” means an offer by NRW to an Eligible Employee to participate in the Plan as set out in an Invitation.
“Participant” means a person who is the holder of a Right under this Plan and includes, as applicable, the Legal
Personal Representative of the person.
“Performance Conditions” means the performance measures, hurdles and tenure conditions (if any) contained
within the Rules that must be satisfied before a Right may vest and convert to Securities, and may include but are
not limited to financial measures relevant to the whole or part of the Group, targets or performance indicators
personal to the Participant and safety measures.
“Performance Period” means the period contained in the Rules for satisfaction of the Performance Conditions.
“Permanent Disability” means the inability, by reason of physical condition, mental illness or accident, of the
Participant to perform substantially all of the duties of the position in which the Participant has been employed or
appointed (as determined by the Board).
“Plan” means the NRW Holdings Limited Performance Rights Plan established and operated in accordance with
these Terms & Conditions (and for the avoidance of doubt, also in accordance with any additional Terms &
Conditions made pursuant to clause 8.2(a) and any Rules made pursuant to clause 12).
“Qualifying Event” means, in relation to a Participant, the cessation of employment of the Participant with the
Group due to his or her death or Permanent Disability or otherwise in circumstances that the Board determines is
a “Qualifying Event”, or subject to the Rules, retrenchment by reason of redundancy.
19
“Reconstruction” means any consolidation, subdivision, reduction, capital return, share split, buy back or
cancellation or other change in the existing capital of NRW.
“Related Bodies Corporate” means a wholly owned subsidiary or entity controlled by NRW.
“Right” means a right granted under this Plan to acquire one Security on conversion of the Right where such
conversion is permitted by and in accordance with this Plan.
“Rules” means the rules made by the Board pursuant to clause 12 and for the avoidance of all doubt includes any
terms or conditions to the Rights as contained within any Invitation.
“Securities” means fully paid ordinary shares in NRW.
“Security Holder” means a holder of Securities in NRW.
“Tax Act” means the Income Tax Assessment Act 1936 (Cth), the Income Tax Assessment Act 1997 (Cth) and
any amendments thereto or any additional legislation as it applies to employee share schemes as defined under
the Tax Act.
“Tax” includes any tax (whether direct or indirect), levy, impost, deduction, charge, rate, contribution, duty or
withholding which is assessed (or deemed to be assessed), levied, imposed or made by any government or any
governmental, semi-governmental or judicial entity or authority together with any interest, penalty, fine, charge, fee
or other amount assessed (or deemed to be assessed), levied, imposed or made on or in respect of any or all of
the foregoing.
“Terms & Conditions” means these terms and conditions governing the Plan as amended from time to time, and
for the avoidance of doubt, includes any additional Terms and Conditions made pursuant to clause 8.2(a).
“Third Party Right” means:
(a) any third party interest, including a mortgage, charge, assignment by way of security, lien, pledge,
hypothecation, title retention arrangement, preferential right or a trust or equity arrangement, a right of
any person to purchase or use an asset (including under an option or agreement to purchase);
(b) any arrangement having a commercial effect equivalent to anything in (a); and
(c) any agreement to create an interest described in (a) or an arrangement described in (b).
“Threshold Hurdle” means any hurdle test or tests included in any Invitation that, when applied, determine in
respect of any grant of Rights the number of such Rights that will become eligible to vest (if any) and the number
of such Rights that will lapse (if any) after application of those tests.
“Vesting Date” means the date on which a Right may vest as specified under the Rules or as amended by the
Board under these Terms & Conditions, and if that date falls on a non Business Day, the Vesting Date shall be the
next Business Day.
2.2 Interpretation
In these Terms & Conditions unless the contrary intention appears:
(a) the term “acquired” in relation to Securities, and grammatical variations of that terms, where used in these
Terms & Conditions, refer to Securities being transferred or allotted, as the case may be;
(b) the singular includes the plural and vice versa;
(c) reference to a person includes the legal representative of that person and also bodies corporate,
unincorporated associations and other legal entities recognised by law;
(d) a reference to any legislation, policy or class order or to a provision of any legislation, policy or class order
includes any modification or re-enactment of it, any provision substituted for it and all regulations and
statutory instruments issued under it;
(e) the expressions “including”, “such as” and similar words or expressions are not words or expressions of
limitation;
(f) where any word or phrase is defined in these Terms & Conditions, any part of speech or other grammatical
form of that word or phrase has a corresponding meaning;
(g) where the Terms & Conditions require or envisage that something will occur or be done on a certain day
and that day is not a Business Day, that thing may occur or be done on the next Business Day;
(h) a reference to a clause is a reference to a clause of these Terms & Conditions;
(i) these Terms & Conditions are to be interpreted in a manner that is consistent with the objects of the Plan
stated in clause 1.2; and
(j) this Plan is intended to comply with the tax deferral conditions of the employee share scheme provisions
set out in the Tax Act and in the event of any ambiguity, these Terms & Conditions and Rules are to be
interpreted so that the Plan complies with the tax deferral conditions set out in the Tax Act.
20
2.3 Headings
Headings in this document are for convenience only and do not affect its meaning.
Omission of certain provisions
If (but for this clause) a provision of this document would be illegal, void or unenforceable or contravene the law,
this document is to be interpreted as if the provision was omitted.
3
OPERATION OF THE PLAN
3.1 Invitation to participate
Subject to these Terms & Conditions, the Board may from time to time invite an Eligible Employee to participate in
the Plan and grant Rights to an Eligible Employee, as part of the Eligible Employee’s remuneration.
3.2 Form of Invitation
An Invitation may be in such form and content as the Board determines, including, if applicable:
(a)
(b)
(c)
(d)
The Threshold Hurdle (if any);
The Performance Period (if any);
The Performance Conditions (if any); and,
The Vesting Date.
3.3 Rights subject to the Plan
Rights will at all times be subject to these Terms & Conditions and the Rules.
3.4 Binding nature of these Terms & Conditions
The Plan shall operate in accordance with these Terms & Conditions, which binds NRW and each Participant.
3.5 Issue or On-Market Acquisition of Securities
Any Securities to be acquired by a Participant on conversion of a Right under the Plan may be delivered to a
Participant at the absolute discretion of the Board, by either the issue to or transfer of Securities to the Participant,
or a combination thereof.
3.6 Ranking of Securities
Securities delivered under the Plan (upon conversion of Rights) will rank equally with all existing Securities on and
from the Date of Registration in respect of all Security holder entitlements (including rights issues, bonus issues
and dividends) which have a record date for determining entitlements on or after the Date of Registration.
3.7 Maximum Number Rights
Subject to the ASIC Instrument (as applicable), the maximum number of Rights that may be granted at any time is
as follows: Securities on issue at Grant Date x 5% minus Rights issued before the Grant Date that at the Grant
Date have not lapsed or been forfeited or vested and converted to Securities
3.8 Quotation of Securities and Rights
(a) If Securities acquired under the Plan are not quoted on the official list of ASX, NRW must apply for
quotation of those Securities on the official list of ASX, or an alternative public securities exchange, as
soon as practicable after the allotment of those Securities. NRW Holdings Limited Performance Rights
Plan Terms & Conditions
(b) Rights will not be quoted on the ASX or any other public securities exchange.
4
LIMITATIONS ON OFFERS OF RIGHTS
4.1 Overriding Restrictions
Notwithstanding anything else in these Terms & Conditions, the Plan must be operated in accordance with the
Constitution, any Applicable Law, the Listing Rules and the ASX Settlement Operating Rules.
21
4.2 No assignment
Unless the Board determines otherwise, a Participant must not assign to any other person any of their legal or
equitable rights to Rights held under the Plan, except a Participant’s Legal Personal Representative to be delivered
Securities upon conversion of Rights.
4.3 Third Party Interests over Rights
Participants must not grant any Third Party Interest over or otherwise deal with any Right or Securities to which a
Right may convert or in any way hedge or otherwise limit their exposure to loss of the Right or reduction in value
of the Security to which the Right may convert.
4.4 Expiry or Lapse of Rights
Rights of a Participant will expire or lapse in accordance with the Rules on the earlier of:
(a) The application of any Threshold Hurdle to the extent that the Rules specify if any Threshold Hurdle is not
met;
(b) a Vesting Date to the extent that the Rules specify if the Performance Conditions applied or tested on that
Vesting Date are not satisfied;
(c) a Control Event occurring:
i.
to the extent that any Rights are not eligible to vest on a Control Event occurring; and
ii.
in respect of any Rights that are eligible to vest on a Control Event occurring, to the extent that
the Rules specify if the Performance Conditions applied or tested on the date on which that
Control Event occurs are not satisfied;
(d) a Reconstruction, but only to the extent that there is a requirement under clause 7.3 to reduce the number
of Rights;
(e) the termination or resignation of employment of a Participant, subject to a determination of the Board
under clause 6.4;
(f) the Participant undertaking any action that is prohibited by these Terms and Conditions or by the Rules,
unless approved by the Board; or
(g) any other event or act or omission as determined by the Board in its absolute discretion.
4.5 Effect of Expiry or Lapse
On the expiry or lapse of a Right, all rights of a Participant under the Plan in respect of that Rights cease and no
consideration or compensation will be payable for or in relation to that expiry or lapse of the Right.
5 STATEMENT
NRW or its agent must maintain a register of Rights and provide, or make available to a Participant:
(a) A statement or other record of Rights held at the time of each grant of Rights and on conversion, expiry
or lapse of Rights; and
(b) A holding statement for Securities allotted on conversion of Rights supplied in accordance with the ASX
Settlement Operating Rules.
6
VESTING AND CONVERSION OF RIGHTS
6.1 No Interest
A grant of Rights does not confer any legal or equitable interests in Securities until the conversion of the Rights to
Securities.
6.2 Achievement of Performance Conditions
The Board may, in its absolute discretion, determine that Rights vest or do not vest:
(a) based on the application of the performance Conditions and the Rules; or
(b) for other reasons that the Board considers in its discretion are appropriate despite the Performance
Conditions being satisfied.
6.3 Vesting and Conversion
Rights which have not expired or lapsed under clause 4.4 will on the latter of the Vesting Date or the date of the
determination by the Board as to the satisfaction of any Performance Conditions, vest and, subject to the Rules,
the Rights will convert and NRW, will at the election of the Board issue, or procure the purchase or transfer of and
22
deliver, to a Participant the number of Securities equal to the number of Performance Rights held by that Participant
that convert under the terms of this Plan.
6.4 Qualifying Reason
Subject to clause 7.4, the Board may, either at its discretion or as it may have prescribed in the Rules, on or after
the occurrence of a Qualifying Event, vary the Vesting Date or waive or vary any Performance Conditions or
Performance Period or a combination thereof to allow the vesting and conversion, expiry or lapse, of Rights.
7
PRO RATA ISSUES, RECONSTRUCTIONS OF CAPITAL, TAKEOVERS AND TERMINATION BENEFITS
7.1 No Right as Participant to Participate in Issues
A Participant is not entitled, by virtue of any Rights that it holds, to participate in:
(a) new issues of Securities to Security Holders;
(b) bonus issues of Securities or other securities to Security Holders; or
(c) any pro-rata issue of Securities to Security Holders.
7.2 Participant rights as Security Holder
To the extent that the Participant or any party related to the Participant is a Security Holder, the Participant is
entitled to participate, and nothing in these Terms and Conditions or the Plan prohibits the Participant from
participating, subject always to any applicable laws or Listing Rules, in any event of the nature listed in paragraphs
(a), (b) or (c) of clause 7.1.
7.3 Reconstructions
In the event of any Reconstruction the number of Securities that may be acquired by each Participant on the
conversion of any Rights must be adjusted equivalently such that each Right will convert into one Security and the
proportion of Securities into which the total number of Rights convert will be the same taking into account the
number of Securities on issue after such Reconstruction (Adjustment). Such Adjustment shall be affected in a
manner that does not result in any additional benefits being conferred on Participants that are not conferred on
Security Holders.
Notwithstanding any other provision of these Terms & Conditions, the terms of the Rights will be changed to comply
with the Listing Rules applicable to a Reorganisation at the time of the Reorganisation.
7.4 Control Event
If there is a Control Event, the Board shall, subject to the Listing Rules give written notice to each Participant as
soon as is practically possible after the occurrence of the Control Event that states:
(a) The date on which the Control Event occurred;
(b) The total number of Rights that the Participant held on the date on which the Control Event occurred, and
from that number of Rights:
i.
The number of Rights that, according to the Rules, expire or lapse due to the Control Event
occurring; and consequently
ii.
The number of Rights that are eligible to vest (being the balance of the total number of Rights
held by that Participant on the date on which the Control Event occurred) (Control Event Eligible
Rights); and
iii.
In respect of the Control Event Eligible Rights, how many of the Control Event Eligible Rights will
vest based on the Board’s application of the Performance Conditions to the Control Event Eligible
Rights, and consequently how many of those Control Event Eligible Rights will expire or lapse
(being the balance of the Control Event Eligible Rights).
7.5 Termination Benefits
Nothing in these Terms and Conditions authorises the Board to provide any benefit to a Participant that, without
Security Holder approval, would be prohibited under the Corporations Act or the Listing Rules.
8
ADMINISTRATION OF THE PLAN
8.1 Amendment
Subject to clause 4.1, these Terms & Conditions may be amended at any time and from time to-time by the Board.
23
8.2 Powers of the Board
Subject to clause 4.1, the Plan will be managed by the Board, which will have power to:
(a) make and amend existing and/or additional Terms & Conditions and/or procedures for the operation,
control and administration of the Plan and any matter incidental to the Plan;
(b) resolve conclusively all questions of fact or interpretation arising in connection with the Plan or the
application of the Rules;
(c) determine matters falling for determination in connection with the Plan or the Rules;
(d) delegate to any one or more persons (for such period and on such conditions as it may determine) the
exercise of any of its functions, powers or discretions arising under the Plan;
(e) establish a trust, if required, to acquire, hold and deliver Securities under the Plan, the establishment of a
trust to be governed by a separate trust deed;
(f) appoint (and remove) an Administrator to administer the Plan and determine the terms and conditions of
the Administrator’s appointment (and removal), the appointment (and removal) of an Administrator to be
governed by a separate agreement; and
(g) delegate to the Managing Director or the Chairman of the Board the authority to approve in writing the
taking of such action as may be reasonably necessary or desirable to implement or effect the Plan (and
where the action involves the Managing Director’s interests in Securities, the Chairman is delegated
authority to approve in writing the action and the Managing Director is precluded from receiving or acting
upon any such delegation), including without limitation:
i.
determining the method of allocation of Securities (as the case may be) for the purposes of
Clause 3.5 or Securities under Clause 6.3; and
ii.
should Securities be acquired on-market in accordance with Clause 3.5, authorising the
purchase (on-market) of the Securities and causing their registration in the name of each
Participant.
8.3 Discretion
A determination, decision, approval or opinion of the Board under these Terms & Conditions (or any additional
Terms & Conditions made under clause 8.2(a) or Rules made under clause 12) is in the absolute unfettered
discretion of the Board.
8.4 Decision Final
The determination, decision, approval or opinion of the Board in respect of any matter relating to the Plan or the
Rules will be final. Any calculations or adjustments which are required to be made under the Plan or the Rules will
be made by the Board and will, in the absence of manifest error, be final and conclusive and binding on the
Participants.
8.5 Commencement of Plan
The original Plan took effect on and from 1 July 2019, and was subsequently re-approved by shareholders at the
2023 Annual General Meeting..
8.6 Termination or suspension of Plan
The Board may terminate or suspend the operation of the Plan at any time, provided that termination or suspension
does not affect or prejudice a Participant’s Rights or rights under the Plan existing at that time.
8.7 Termination or suspension of Participant
The Board may terminate or suspend the participation of a Participant in the Plan at any time.
8.8 Disclosure of Information
NRW and/or the Administrator may disclose such information of a Participant as required by the Tax Act to any
relevant government authority including, without limitation a Participant’s tax file number and number or value of
Rights granted and/or vested or Securities acquired under clause 6.2.
9
EMPLOYMENT RIGHTS
9.1 No entitlements
If the Plan or the participation of a Participant is terminated or suspended at any time under clause 8.6 or clause
8.7, no compensation under any employment contract will arise as a result. Participation in the Plan in one year
does not give rise to any entitlement to participate in the Plan in any subsequent year.
24
9.2 No right to acquire Securities
Participation in the Plan does not confer on any Participant any right to acquire Securities under the Plan, other
than under and in accordance with the Plan and the Rules.
9.3 Calculation of employee benefits
The value of Rights or Securities (as the case may be) allocated under the Plan does not increase a Participant’s
income for the purpose of calculating any employee benefits.
9.4 No right to future employment
Participation in the Plan does not confer on any Participant any right to continue as an employee of the Group.
9.5 Termination of employment
Participation in the Plan does not affect any rights which the Group may have to terminate the employment of any
Participant. Nothing in the Terms & Conditions, including participation in the Plan, may be used to increase
damages in any action brought against the Group in respect of any termination of employment with the Group.
9.6 Security holder entitlements
Rights do not confer on the Participant that holds those Rights any benefit or entitlement other than as stated in
these Terms and Condition or the Rules. There is no entitlement to dividends on Rights or to any entitlements
attaching to Securities.
10 NOTICES
10.1 Notice to Participants
Any notice or direction given under these Terms & Conditions is validly given to a Participant if it is handed to the
Participant concerned or sent by ordinary prepaid post to the Participant’s last known address or sent to the email
address last notified by the Participant or if no such address is notified then the Participant’s NRW email address.
10.2 Notice to NRW
Any notice given by a Participant to NRW under these Terms & Conditions must be given in writing and delivered
to the Company Secretary of NRW Holdings Limited by hand, post or by email and if by email to the NRW email
address of the Company Secretary.
10.3 Receipt of notices
Notices are taken to be received:
(a) if hand delivered, on delivery;
(b) if sent by prepaid post, five Business Days after the date of posting;
(c) if by electronic mail, when the electronic communication enters the recipient’s information system(s).
11 PLAN COSTS AND EXPENSES
11.1 Costs of NRW
Subject to clauses 11.2 and 11.3, unless otherwise determined by the Board, NRW must pay all costs relating to
the establishment and operation of the Plan, including all costs and expenses in relation to the delivery of the Rights
and/or Securities except that NRW is not responsible for any Taxes which may become payable by a Participant
in connection with the Rights or Securities (as the case may be) or any other dealing with the Rights or Securities
(as the case may be).
11.2 Costs of Participants
Each Participant will pay all costs and expenses in relation to the sale, transfer or other disposal of any Securities
acquired upon conversion of Rights under the Plan and to any advice a Participant seeks in relation to its
participation in the Plan or issue of any Rights or Securities under the Plan.
25
11.3 Withholding Tax
NRW or any Group company may withhold from amounts otherwise owing to a Participant, or require the Participant
to remit to it, an amount sufficient to satisfy all withholding tax obligations and any government imposts, in respect
of any or all of the Rights issued, or Securities issued or transferred on conversion of the Rights, under the Plan.
12 RULES
The Board may apply, make and/or amend Rules for the operation of the Plan or its application to an individual
Eligible Employee, not inconsistent with these Terms & Conditions and those Rules shall apply for each grant of
Rights.
13 GOVERNING LAW AND JURISDICTION
The laws of the State of Western Australia, Australia, govern these Terms & Conditions and the rights of the
Participants thereunder. Each Participant irrevocably and unconditionally submits to the exclusive jurisdiction of
the courts of the State of Western Australia, Australia and courts entitled to hear appeals from those courts.
26
LODGE YOUR VOTE
ONLINE
https://au.investorcentre.mpms.mufg.com
BY MAIL
NRW Holdings Limited
C/- MUFG Corporate Markets (AU) Limited
Locked Bag A14
Sydney South NSW 1235 Australia
ABN 95 118 300 217
FAX
BY
+61 2 9287 0309
HAND
BY
MUFG Corporate Markets (AU) Limited
Parramatta Square, Level 22, Tower 6,
10 Darcy Street, Parramatta NSW 2150
ENQUIRIES TO
ALL
Telephone: 1300 554 474
Overseas: +61 1300 554 474
X99999999999
X99999999999
PROXY FORM
I/We being a member(s) of NRW Holdings Limited and entitled to participate in and vote hereby appoint:
APPOINT A PROXY
OR if you are NOT appointing the Chairman of the Meeting
as your proxy, please write the name of the person or
body corporate you are appointing as your proxy
or failing the person or body corporate named, or if no person or body corporate is named, the Chairman of the Meeting, as my/our proxy
to act on my/our behalf (including to vote in accordance with the following directions or, if no directions have been given and to the extent
permitted by the law, as the proxy sees fit) at the Annual General Meeting of the Company to be held at 2:00pm (Perth time) on
Thursday, 26 November 2026 at 219 St Georges Terrace, Perth, Western Australia (the Meeting) and at any postponement or
adjournment of the Meeting.
Important for Resolutions 1, 3, 4 & 5: If the Chairman of the Meeting is your proxy, either by appointment or by default, and you have
not indicated your voting intention below, you expressly authorise the Chairman of the Meeting to exercise the proxy in respect of
Resolutions 1, 3, 4 & 5, even though the Resolutions are connected directly or indirectly with the remuneration of a member of the
Company’s Key Management Personnel (KMP).
The Chairman of the Meeting intends to vote undirected proxies in favour of each item of business.
STEP 1
the Chairman of the
Meeting (mark box)
VOTING DIRECTIONS
Proxies will only be valid and accepted by the Company if they are signed and received no later than 48 hours before the Meeting.
Please read the voting instructions overleaf before marking any boxes with an T
Resolutions
STEP 2
1 Remuneration Report
For Against Abstain*
For Against Abstain*
5 Non-executive Directors’ fees
2 Re-election of Mr. David Joyce
3 Approval of Performance Rights Plan
mark the Abstain box for a particular Item, you are directing your proxy not to vote on your behalf on a show of hands or on a poll and your votes will not be counted
* Iinf you
computing the required majority on a poll.
STEP 3
SIGNATURE OF SHAREHOLDERS – THIS MUST BE COMPLETED
Shareholder 1 (Individual)
Joint Shareholder 2 (Individual)
Joint Shareholder 3 (Individual)
Sole Director and Sole Company Secretary
Director/Company Secretary (Delete one)
Director
This form should be signed by the shareholder. If a joint holding, either shareholder may sign. If signed by the shareholder’s attorney, the
power of attorney must have been previously noted by the registry or a certified copy attached to this form. If executed by a company, the
form must be executed in accordance with the company’s constitution and the Corporations Act 2001 (Cth).
NWH PRX2602C
NWH PRX2602C
4 Approval of grant of performance
rights for FY27 to Mr Julian Pemberton
under the NRW Holdings Limited
Performance Rights Plan
HOW TO COMPLETE THIS SHAREHOLDER PROXY FORM
YOUR NAME AND ADDRESS
This is your name and address as it appears on the Company’s share
register. If this information is incorrect, please make the correction on
the form. Shareholders sponsored by a broker should advise their broker
of any changes. Please note: you cannot change ownership of your
shares using this form.
APPOINTMENT OF PROXY
If you wish to appoint the Chairman of the Meeting as your proxy, mark
the box in Step 1. If you wish to appoint someone other than the Chairman
of the Meeting as your proxy, please write the name of that individual or
body corporate in Step 1. A proxy need not be a shareholder of the
Company.
LODGEMENT OF A PROXY FORM
This Proxy Form (and any Power of Attorney under which it is signed)
must be received at an address given below by 2:00pm (Perth time)
on Tuesday, 24 November 2026, being not later than 48 hours before
the commencement of the Meeting. Any Proxy Form received after
that time will not be valid for the scheduled Meeting.
Proxy Forms may be lodged using the reply paid envelope or:
Login to the Investor Centre using the holding details as shown
on the Voting/Proxy Form. Select ‘Voting’ and follow the
prompts to lodge your vote. To use the online lodgement facility,
shareholders will need their “Holder Identifier” - Securityholder
Reference Number (SRN) or Holder Identification Number (HIN).
DEFAULT TO CHAIRMAN OF THE MEETING
Any directed proxies that are not voted on a poll at the Meeting will default
to the Chairman of the Meeting, who is required to vote those proxies as
directed. Any undirected proxies that default to the Chairman of the
Meeting will be voted according to the instructions set out in this Proxy
Form, including where the Resolutions are connected directly or indirectly
with the remuneration of KMP.
BY MOBILE DEVICE
Our voting website is designed specifically
for voting online. You can now lodge your
vote by scanning the QR code adjacent or
enter the voting link
https://au.investorcentre.mpms.mufg.com
into your mobile device. Log in using the
Holder Identifier and postcode for your
shareholding.
VOTES ON ITEMS OF BUSINESS – PROXY APPOINTMENT
You may direct your proxy how to vote by placing a mark in one of the
boxes opposite each item of business. All your shares will be voted in
accordance with such a direction unless you indicate only a portion of
voting rights are to be voted on any item by inserting the percentage or
number of shares you wish to vote in the appropriate box or boxes. If you
do not mark any of the boxes on the items of business, your proxy may
vote as they choose. If you mark more than one box on an item your vote
on that item will be invalid.
APPOINTMENT OF A SECOND PROXY
BY MAIL
NRW Holdings Limited
C/- MUFG Corporate Markets (AU) Limited
Locked Bag A14
Sydney South NSW 1235
Australia
BY FAX
+61 2 9287 0309
BY HAND
delivering it to MUFG Corporate Markets (AU) Limited*
Parramatta Square
Level 22, Tower 6
10 Darcy Street
Parramatta NSW 2150
SIGNING INSTRUCTIONS
You must sign this form as follows in the spaces provided:
Individual: where the holding is in one name, the holder must sign.
Joint Holding: where the holding is in more than one name, either
shareholder may sign.
Power of Attorney: to sign under Power of Attorney, you must lodge the
Power of Attorney with the registry. If you have not previously lodged this
document for notation, please attach a certified photocopy of the Power
of Attorney to this form when you return it.
Companies: where the company has a Sole Director who is also the Sole
Company Secretary, this form must be signed by that person. If the
company (pursuant to section 204A of the Corporations Act 2001) does
not have a Company Secretary, a Sole Director can also sign alone.
Otherwise this form must be signed by a Director jointly with either another
Director or a Company Secretary. Please indicate the office held by signing
in the appropriate place.
CORPORATE REPRESENTATIVES
If a representative of the corporation is to attend the Meeting the
appropriate “Certificate of Appointment of Corporate Representative”
must be received at [email protected] prior to admission
in accordance with the Notice of Annual General Meeting. A form of
the certificate may be obtained from the Company’s share registry
or online at www.mpms.mufg.com/en/mufg-corporate-markets.
QR Code
To scan the code you will need a QR code reader application
which can be downloaded for free on your mobile device.
You are entitled to appoint up to two persons as proxies to participate in
the Meeting and vote on a poll. If you wish to appoint a second proxy, an
additional Proxy Form may be obtained by telephoning the Company’s
share registry or you may copy this form and return them both together.
To appoint a second proxy you must:
(a) on each of the first Proxy Form and the second Proxy Form state the
percentage of your voting rights or number of shares applicable to that
form. If the appointments do not specify the percentage or number of
votes that each proxy may exercise, each proxy may exercise half your
votes. Fractions of votes will be disregarded; and
(b) return both forms together.
ONLINE
https://au.investorcentre.mpms.mufg.com
*During business hours Monday to Friday (9:00am - 5:00pm)
COMMUNICATION PREFERENCE
We encourage you to receive all your shareholder communication via
email. This communication method allows us to keep you informed without
delay, is environmentally friendly and reduces print and mail costs.
ONLINE
https://au.investorcentre.mpms.mufg.com
Login to the Investor Centre using the holding details as shown on the
Proxy Form. Select ‘Communications’ and click the first button to receive
all communications electronically and enter your email address. To use
the online facility, shareholders will need their “Holder Identifier” Shareholder Reference Number (SRN) or Holder Identification Number
(HIN).
IF YOU WOULD LIKE TO PARTICIPATE IN AND VOTE AT THE ANNUAL GENERAL MEETING, PLEASE BRING THIS FORM WITH YOU.
THIS WILL ASSIST IN REGISTERING YOUR ATTENDANCE.